Intuitive Surgical, Inc. $ISRG Stock Position Cut by Strategic Blueprint LLC

Strategic Blueprint LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.5% in the 2nd quarter, HoldingsChannel reports. The fund owned 3,507 shares of the medical equipment provider’s stock after selling 52 shares during the period. Strategic Blueprint LLC’s holdings in Intuitive Surgical were worth $1,906,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of ISRG. Norway Savings Bank grew its holdings in Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after acquiring an additional 910 shares during the period. IronOak Wealth LLC. acquired a new stake in shares of Intuitive Surgical during the 2nd quarter valued at $1,099,000. Trust Co. of Oklahoma acquired a new position in shares of Intuitive Surgical in the 2nd quarter worth $363,000. Neville Rodie & Shaw Inc. boosted its position in shares of Intuitive Surgical by 11.9% in the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after purchasing an additional 1,110 shares during the period. Finally, Sax Wealth Advisors LLC lifted its stake in Intuitive Surgical by 218.1% during the second quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after buying an additional 1,684 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $551.30 on Friday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market capitalization of $197.63 billion, a price-to-earnings ratio of 72.92, a PEG ratio of 5.53 and a beta of 1.61. The stock’s 50 day simple moving average is $456.77 and its 200 day simple moving average is $496.40.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the prior year, the firm earned $1.84 EPS. Intuitive Surgical’s quarterly revenue was up 22.9% compared to the same quarter last year. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director owned 1,074 shares in the company, valued at approximately $504,898.14. The trade was a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,724 shares of company stock valued at $19,500,332 in the last three months. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research analyst reports. Evercore ISI lowered their price objective on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 7th. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, October 18th. Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday. Leerink Partners lifted their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Eighteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $604.50.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.